David L. Bartlett, MD, a renowned cancer researcher and clinician specializing in advanced surgical treatments for abdominal cancers, has reopened his Pittsburgh practice.
PITTSBURGH, Pa.– David L. Bartlett, MD, a renowned cancer researcher and clinician specializing in advanced surgical treatments for abdominal cancers, has reopened his Pittsburgh practice and has begun seeing patients at AHN Cancer Institute – Allegheny General. Appointments are now being accepted.
Dr. Bartlett joined AHN in May 2020 as Chair of AHN Cancer Institute and began his AHN surgical practice at Saint Vincent Hospital in Erie. He will continue to see patients in Erie, in addition to his Pittsburgh practice.
“I am excited to begin seeing patients in Pittsburgh, and to collaborate with the team of outstanding caregivers at AHN Cancer Institute to provide comprehensive, compassionate care to current and new patients,” Dr. Bartlett said. “It has also been a pleasure over the past year to work with the team at AHN Saint Vincent to care for patients from Erie and surrounding areas, and I’m happy to be able to continue seeing patients there.”
“Over the past year we have made progress in leading AHN Cancer Institute to greater heights of excellence. Our milestones have included the opening of the $80 million, patient-centered AHN Cancer Institute – Allegheny General, and the new Clinical Genomics Laboratory, offering next-generation gene sequencing that guides physicians in selecting the best treatment for each individual patient.
“This year, we will also begin offering patients two highly advanced radiation treatments, both available at only a few centers nationwide: the MR-linac and Gamma Pod. The MR-linac offers patients the most personalized radiation therapy possible for their specific diagnosis and tumor characteristics. Gamma Pod, the first radiation treatment designed exclusively for breast cancer patients, delivers high-dose, precise radiation in as little as one to five treatments. In addition, we have successfully recruited nationally known physicians to join our team and expect to announce additional physician appointments in the coming months.”
As chair, Dr. Bartlett oversees a multidisciplinary team of more than 200 physicians and 500 advanced-practice oncology professionals. Clinicians within the Institute annually deliver more than 150,000 cancer treatments to more than 11,000 patients at clinical sites across western Pennsylvania.
Dr. Bartlett came to AHN from the University of Pittsburgh Medical Center, where he held several leadership positions in research and surgical oncology. A graduate of the University of Texas School of Medicine, Dr. Bartlett completed a residency in general surgery at the Hospital of the University of Pennsylvania, in Philadelphia, and a fellowship in surgical oncology at Sloan-Kettering Cancer Center in New York. He also performed clinical research at MD Anderson Cancer Center in Houston.
Dr. Bartlett helped to develop and refine new regional perfusion techniques, including the modern version of the hyperthermic intraperitoneal chemoperfusion (HIPEC) therapy, in which chemotherapeutic drugs are heated and delivered directly into the abdominal cavity in an effort to eradicate cancer cells. He is also known for his cutting-edge research into viral-based immune therapies.
Dr. Bartlett sees adult patients for the surgical treatment of abdominal cancers, including gastric, pancreatic, colorectal and appendix cancers, as well as care for sarcoma, neuroendocrine and liver tumors, and peritoneal metastases. His Pittsburgh clinic is located at 314 E. North Avenue within AHN Cancer Institute-Allegheny General. Appointments may be made by calling 833-AHN-SONC.
*Originally published on AHN.org.